Skip to main content
. 2019 Jun 10;11(6):803. doi: 10.3390/cancers11060803

Figure 3.

Figure 3

Survival curves showing the overall survival (OS) of lung adenocarcinoma patients with and without detectable epidermal growth factor receptor (EGFR) mutations in plasma ctDNA by ARMS.